RNXT
RenovoRx Inc
1.70$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| 0.17 | 0.14 | 0.17 | 0.24 | 0.28 | 0.26 | 0.18 | |
| 0.05 | 0.05 | 0.15 | 0.31 | 0.28 | 0.21 | 0.20 | |
| 0.22 | 0.18 | 0.32 | 0.55 | 0.55 | 0.47 | 0.38 | |
| -0.22 | -0.18 | -0.32 | -0.55 | -0.55 | -0.46 | -0.35 | |
| 0.00 | 0.03 | 0.05 | 0.00 | 0.01 | 0.02 | – | |
| -0.22 | -0.22 | -0.35 | -0.55 | -0.50 | -0.37 | -0.32 | |
| 0.00 | 0.03 | 0.04 | -0.01 | 0.00 | -0.37 | – | |
| -0.22 | -0.22 | -0.35 | -0.54 | -0.50 | -0.37 | -0.32 | |
| -0.22 | -0.19 | -0.31 | -0.55 | -0.49 | -0.37 | -0.32 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.